Glycans in Diseases and Therapeutics

Glycomedicine plays major role in cell-cell adhesion i.e. a mechanism employed by cells of the immune system via sugar-binding proteins called lectins, which recognize specific carbohydrate moieties. Glycans (carbohydrate oligomers) are the so-called “building blocks” of carbohydrates, nucleic acids, proteins and lipids play major roles in many biological phenomena as well as in various pathophysiological processes. Many scientists in other fields of research have now realized that glycosylation, i.e. the addition of glycans to a protein backbone, is the most abundant post translational modification reactions and is an important field of research and sometimes they require a glycobiology and/or glycochemistry approach to be used.

  • Congenital disorders of glycosylation (CDG)
  • Cardiovascular diseases
  • Cancer biomarkers
  • Cancer associated coagulopathies
  • Transfusion medicine
  • Cardiac arrest
  • Glycomedicine

Related Conference of Glycans in Diseases and Therapeutics

September 24-26, 2018

14th International Conference on Structural Biology

Berlin, Germany
October 03-04, 2018 |

4th International Conference on Biochemistry & Metabolomics

Los Angeles, California, USA
October 11-12, 2018

13th International Conference on Metabolomics and Systems Biology

Hilton Zurich Airport Hohenbuehlstrasse 10, 8152, Opfikon, Switzerland
October 18-19, 2018

10th International Congress on Structural Biology

Helsinki, Finland
November 19-20, 2018

15th World Congress on

Structural Biology

Paris, France
February 28-March 01, 2019

5th International Conference on Enzymology and Protein Chemistry

Berlin, Germany
July 31-August 01, 2019

6th International Conference on Glycobiology & Glycoproteomics

Chicago, Illinois, USA

Glycans in Diseases and Therapeutics Conference Speakers

Recommended Sessions

Related Journals

Are you interested in